<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The discovery of pathways and regulatory networks whose perturbation contributes to <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> remains a fundamental challenge for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> biology </plain></SENT>
<SENT sid="1" pm="."><plain>We show that such pathway perturbations, and the cis-regulatory elements through which they operate, can be efficiently extracted from global gene expression profiles </plain></SENT>
<SENT sid="2" pm="."><plain>Our approach utilizes information-theoretic analysis of expression levels, pathways, and genomic sequences </plain></SENT>
<SENT sid="3" pm="."><plain>Analysis across a diverse set of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> reveals the majority of previously known <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> pathways </plain></SENT>
<SENT sid="4" pm="."><plain>Through de novo motif discovery we associate these pathways with transcription-factor binding sites and miRNA targets, including those of E2F, NF-Y, p53, and let-7 </plain></SENT>
<SENT sid="5" pm="."><plain>Follow-up experiments confirmed that these predictions correspond to functional in vivo regulatory interactions </plain></SENT>
<SENT sid="6" pm="."><plain>Strikingly, the majority of the perturbations, associated with putative cis-regulatory elements, fall outside of known <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> pathways </plain></SENT>
<SENT sid="7" pm="."><plain>Our study provides a systems-level dissection of regulatory perturbations in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-an essential component of a rational strategy for therapeutic intervention and drug-target discovery </plain></SENT>
</text></document>